Evolution of therapy for reflux disease: where are we? Where are we going?
JP Galmiche
CHU, Nantes, France
Progress through the module by clicking on the navigation bar below
| Learning > The art of GORD treatment |
|
Evolution of therapy for reflux disease: where are we? Where are we going? JP Galmiche |
|
Progress through the module by clicking on the navigation bar below
|
|
Let us first consider the epidemiology and natural history of gastroesophageal reflux disease. Reflux is a common disorder. Most patients are actually seen in a primary care setting. The majority of those who have symptoms of reflux, do not have mucosal breaks at endoscopy. Reflux is a chronic disorder with a negative impact on quality of life. |
|
 |
All contents copyright© GastroHOPES Ltd unless otherwise noted. GastroHOPES Ltd and Gastro-Pro do not sell products or services. The contents of this website are intended for access by healthcare professionals only. This website is not intended for patient education. Minors and those of a sensitive nature might find some sounds and images on this site distressing. Visitors are invited to read our privacy policy and full legal notice. Last updated 30.10.03 |
